2017 Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US

March 2017 | 1200 pages | ID: 2AF85C5B960EN
Venture Planning Group

Abstracts

Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

VPGMarketResearch.com presents a new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Worldwide Market Overview

• Five-year test volume and sales projections by country.
• Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.
• Estimated universe of laboratories performing cancer diagnostic testing by country.
• Cancer statistics, etiology and recent developments in the

U.S., Europe, and Asia.

Business Opportunities and Strategic Recommendations

• Specific new product development opportunities with potentially significant market appeal during the next five years.
• Design criteria for new products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

• Oncogenes
• Biochemical Markers
• Growth Factors
• Colony Stimulating Factors
• Hormones
• Immunohistochemical Stains
• Lymphokines

Supplier Shares, Sales and Volume Forecasts

• Sales and market shares of major cancer diagnostic product suppliers by individual test and country.
• Five-year test volume and sales forecasts for major tumor markers by country and market segment, including:
• Hospitals
• Commercial/Private Laboratories
• Physician Offices/Group Practices
• Cancer Clinics
• Ambulatory Care Centers

Instrumentation Review

• Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

• Assessment of latest technologies and their potential applications for cancer diagnostic testing.
• Review of competing/complementing technologies.
• Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

The companies analyzed in the report include:

• Abbott
• AdnaGen
• Agilent Technologies
• Applied Gene Technologies
• Arca Biopharma
• Beckman Coulter/Danaher
• Becton Dickinson
• Biomedical Diagnostics
• bioMerieux
• Bio-Rad
• CellSearch
• Cepheid
• Correlogic Systems/Vermillion
• Decode Genetics
• Diadexus
• Diagnocure
• DiaSorin
• Eiken Chemical
• Elitech Group
• Enterix
• Enzo Biochem
• Epigenomics
• Exact Sciences
• Fujirebio
• Guided Therapeutics
• Hologic/Gen-Probe
• Kreatech/Leica
• Kyowa Medex
• Mackay Life Sciences
• Myriad Genetics
• OncoLab
• Ortho-Clinical Diagnostics
• Panacea Pharmaceuticals
• Polartechnics
• Polymedco
• PreMD
• Qiagen
• Quest Diagnostics
• Radient Pharmaceuticals
• Roche
• Scienion
• Sequenom
• Siemens Healthcare
• Takara Bio
• Targeted Diagnostics & Therapeutics
• Thermo Fisher
• Tosoh
• Veridex
• Wako Pure Chemicals
• Wallac/PE
• Zilla/Alere

Contains 1,200 pages and 450 tables

Contents

I. Worldwide Business Environment

II. WORLDWIDE MARKET STRUCTURE

III. MAJOR CURRENT AND EMERGING CANCER DIAGNOSTIC TESTS

1. INTRODUCTION
2. TUMOR MARKER CLASSIFICATION
3. ACTH
4. ALPHA-FETOPROTEIN (AFP)
5. BETA-2 MICROGLOBULIN
6. CA 15-3/27.29
7. CA 19-
8. CA-
9. CALCITONIN
10. CARCINOEMBRIONIC ANTIGEN (CEA)
11. ESTROGEN AND PROGESTERONE RECEPTORS
12. FERRITIN
13. GASTRIN
14. HUMAN CHORIONIC GONADOTROPIN (HCG)
15. INSULIN
16. NSE
17. OCCULT BLOOD
18. PAP SMEAR/HPV
19. PROSTATIC ACID PHOSPHATASE (PAP)
20. PROSTATE-SPECIFIC ANTIGEN (PSA)
21. SQUAMOUS CELL CARCINOMA ANTIGEN (SCC)
22. T AND B LYMPHOCYTES
23. TDT
24. THYROGLOBULIN
25. TISSUE POLYPEPTIDE ANTIGEN (TPA)
26. BIOCHEMICAL TUMOR MARKERS
  ADA
  B-Protein
  PNP
  5'Nucleotidase
27. ONCOGENES
  Abl/abi-bcr
  AIB1
  BCL
  BRCA1
  CD44
  C-fos
  C-myb
  C-myc
  CYP
  Erb-B
  HPC1
  N-myc
  P40
  P51
  P53
  PIK3CA
  PTI
  Ras
  Reg
  Sis
  Src
28. POLYPEPTIDE GROWTH FACTORS
  Basic Fibroblast Growth Factor
  BetaTGF
  Cachectin (TNT)
  Calmodulin
  ECFR
  Nerve Growth Factor (NGF)
  Epidermal Growth Factor (EGF)
  Ornithine Decarboxylase
  Transferrin
  Transforming Growth FactorAlpha
29. ECTOPIC HORMONES
30. COLONY STIMULATING FACTORS
31. LYMPHOKINES
  AlphaInterferon
  B Cell Growth Factors
  B Cell Growth Factor (BCGF)
  GammaInterferon
  Interleukin1 (IL1)
  Macrophage Activating Factor
32. IMMUNOHISTOCHEMICAL STAINS
33. EMERGING TUMOR MARKERS
  N-Acetylglucosamine
  Actin
  AlphaActin
  Antineuronal Antibodies
  7B2
  B72.3
  Bax
  BCD  F9
  BLCA
  Blood Group Antigens A,B,H
  CA
  CA 72  4/TAG
  CA
  CA
  CA
  CAM
  CAR
  CathepsinD
  Chromogranin A and B
  Cluster 1 Antigen
  Cluster5/5A Antigen
  CTA
  CU18
  DR
  DUPAN
  Endometrial Bleeding Associated Factor
  Endostatin
  Epithelial Membrane Antigen
  Feulgen Hydrolysis
  Fibronectin
  FSH
  (1>3)  Lfucosyltransferase
  GastrinReleasing Peptide (GRP)
  GDCFP
  Glucagon
  Glycoamines
  H23
  Her-
  Human Carcinoma Antigen
  HPA
  HSP27
  Intermediate Filaments
  Cytokeratins/CK18/Cyfra 21-
  Desmin
  Gliofibrillary Acid Protein
  Neurofilaments
  Vimentin
  KA
  Kinases
  KP16D3
  LAI
  Leukocyte Common Antigen
  Lewis Antigens
  Lysophosphatidic Acid (LPA)
  Ma 695/Ma
  MABDF3
  MAG
  ME1
  Minactivin
  MN/CA9
  MSA
  Mucin Cancer Antigen (MCA)
  Multiple Tumor Suppressor
  Myosin
  NEA
  NMP22
  OA
  Opiod Peptides
  P  glycoprotein
  Pancreatic Oncofetal Antigen (POA)
  Placental Lactogen
  PR92
  Proliferative Index, Ki-
  Px
  RB Inactivation/Deletion
  Ret
  SCCL
  Selectin
  Sialic Acid
  Sialyl SSEA-1/SLX
  SN10
  Somatostatin
  TA
  TABA
  Tachykinin
  TAG
  TPS
  Troponin
  Tubulin
  VCAM
  VEGF
  Villen

IV. INSTRUMENTATION REVIEW: LEADING ANALYZERS MARKETED BY ABBOTT, BECKMAN COULTER/DANAHER, BINDING SITE, BIOMERIEUX, CAROLINA CHEMISTRIES, DIASORIN, HORIBA, INVERNESS/ALERE, J&J, OLYMPUS, ROCHE, SIEMENS, TOSOH, VITAL DIAGNOSTICS AND OTHER SUPPLIERS

V. CURRENT AND EMERGING TECHNOLOGIES

1. MONOCLONAL AND POLYCLONAL ANTIBODIES
2. IMMUNOASSAYS
  a. Technological Principle
  b. Radioimmunoassay (RIA)
  c. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    Immunofiltration
    Particle-Membrane Capture Immunoassay
    Enzyme Amplification
  d. Fluorescent Immunoassays
  e. Luminescence
    Chemiluminescence
    Bioluminescence
  f. Latex Agglutination
  g. Immunoprecipitation
  H. Affinity Chromatographu
  e. Liposome Flow-Injection Immunoassay
3. MOLECULAR DIAGNOSTICS
  a. Technology Overview
  b. Amplification Methods
    PCR
    DAP-PCR
    Immuno-PCR
    QC-PCR
    CAR
    DNA
    HPA
    LCR
    NASBA
    QBR
    SDA
    3 SR, and others
4. CHROMOSOME ANALYSIS
  a. Chronic Myelogenous Leukemia (CML)
  b. Acute Myeloid Leukemia (AML)
  c. Acute Lymphoblastic Leukemia (ALL)
  d. Malignant Lymphomas Lymphoid Malignancies
  e. Chronic Lymphocytic Leukemia (CLL)
  f. Solid Cancers
  g. Chromosomal Translocation and Oncogenes
5. ARTIFICIAL INTELLIGENCE
6. FLOW CYTOMETRY
7. TWO DIMENSIONAL GEL ELECTROPHORESIS (2  DGE)
8. BIOSENSORS
9. COMPETING/COMPLEMENTING TECHNOLOGIES
  a. CT
  b. MRI
  c. NMR
  d. PET
  e. Photonics Spectroscopy

VI. COMPETITIVE PROFILES

Abbott
AdnaGen
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Hologic/GenProbe
Guided Therapeutics
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen/Ipsogen
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Thermo Fisher
Vermillion/Correlogic Systems
Wako Pure Chemicals
Wallac/PE
Zila
Appendixes: Major Universities and Research Centers Developing Cancer Diagnostic Technologies and Applications

List Of Tables

LIST OF TABLES

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19  9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Worldwide, All Market Segments, Laboratories Performing Cancer Diagnostic Testing By Country
Worldwide, All Market Segments, Cancer Diagnostic Test Volume Forecasts By Country
Worldwide, All Market Segments, Cancer Diagnostics Sales Forecasts By Country"
"LIST OF TABLES

Clinical Chemistry and Immunodiagnostics Market
Infectious Disease Testing Market Cancer Diagnostic Testing Market Molecular Diagnostic Testing Market Hematology and Flow Cytometry Testing Market Coagulation Testing Market Blood Banking Testing Market "
"LIST OF TABLES

Infectious Disease Testing Market Molecular Diagnostic Testing Market "
"SECTION I: EXECUTIVE SUMMARY

A 4-9 page synopsis of key sections.

SECTION II: OWNERSHIP

Background of parent companies, private owners, and shareholder information.

SECTION III: BUSINESS EVOLUTION

History of the company’s formation, which is important to understanding the corporate culture, management mentality, and future strategies.
Business evolution milestone charts.

SECTION IV: ORGANIZATION AND MANAGEMENT

Most recent acquisitions, divestitures, and organizational changes.
Current organizational structure.
Background of senior managers.

SECTION V: MAJOR FACILITIES AND EMPLOYEES

Production, compounding, creative, and R&D facilities by country.
Workforce size.

SECTION VI: PRODUCT PORTFOLIO AND TECHNOLOGICAL KNOW-HOW

Major products and services, including fragrances (fine, technical), flavors, aroma chemicals (high-volume standard products, high-volume specialties, low-volume specialties), essential oils, and others.
Know-how in chemical technology, biotechnology, aromacology and related fields.

SECTION VII: MARKETING CAPABILITIES

Sales force size by country.
Major sale office locations.
Marketing tactics.

SECTION VIII: FINANCIAL ANALYSIS

Sales estimates by product category and geographic region.
Five-year sales and operating profit performance.

SECTION IX: STRENGTHS AND WEAKNESSES

Organizational
Technological
Marketing
Financial

SECTION X: STRATEGIC DIRECTION

Business goals and strategies, including internal expansion, acquisitions, and divestitures.

LIST OF TABLES

Table MO-1: WORLD FLAVOR AND FRAGRANCE MARKET FORECAST BY GEOGRAPHIC REGION
Table MO-2: WORLD FLAVOR AND FRAGRANCE MARKET FORECAST BY PRODUCT CATEGORY
Table FI-1: FIRMENICH OPERATIONS BY COUNTRY
Table FI-2: FIRMENICH FRAGRANCE INTRODUCTIONS
Table FI-3: FIRMENICH SALES AND OPERATING PROFIT GROWTH
Table FI-4: FIRMENICH SALES BY GEOGRAPHIC REGION
Table FI-5: FIRMENICH SALES BY PRODUCT CATEGORY
Table FR-1: FRUTAROM FRAGRANCE INTRODUCTIONS
Table FR-2: FRUTAROM SALES BY PRODUCT CATEGORY
Table FR-3: FRUTAROM SALES AND OPERATING PROFIT GROWTH
Table FR-4: FRUTAROM SALES BY GEOGRAPHIC REGION
Table FR-5: FRUTAROM SALES GROWTH BY GEOGRAPHIC REGION
Table FR-6: FRUTAROM SALES GROWTH BY PRODUCT CATEGORY
Table GI-1: GIVAUDAN BUSINESS EVOLUTION MAJOR MILESTONES
Table GI-2: GIVAUDAN SALES AND OPERATING PROFIT GROWTH
Table GI-3: GIVAUDAN SALES GROWTH BY GEOGRAPHIC REGION
Table GI-4: GIVAUDAN SALES GROWTH BY PRODUCT CATEGORY
Table HA-1: T. HASEGAWA FRAGRANCE INTRODUCTIONS
Table HA-2: T. HASEGAWA SALES AND OPERATING PROFIT GROWTH
Table HA-3: T. HASEGAWA SALES BY GEOGRAPHIC REGION
Table HA-4: T. HASEGAWA SALES BY PRODUCT CATEGORY
Table HA-5: T. HASEGAWA FRAG. SALES BY GEOGRAPHIC REGION
Table HAF-6: T. HASEGAWA FLAVOR SALES BY GEOGRAPHIC REGION
Table HA-7: T. HASEGAWA FRAGRANCE SALES BY PRODUCT CATEGORY
Table HA-8: T. HASEGAWA FLAVOR SALES BY PRODUCT CATEGORY
Table IF-1: IFF SALES GROWTH
Table IF-2 IFF SALES BY PRODUCT CATEGORY
Table MA-1: MANE FRAGRANCE INTRODUCTIONS
Table MA-2: MANE SALES AND OPERATING PROFIT GROWTH
Table MA-3: MANE SALES BY GEOGRAPHIC REGION
Table MA-4: MANE SALES GROWTH BY GEOGRAPHIC REGION
Table MA-5: MANE SALES BY PRODUCT CATEGORY
Table MA-6: MANE SALES GROWTH BY PRODUCT CATEGORY
Table RO-1: ROBERTET SALES AND PROFIT GROWTH
Table RO-2: ROBERTET SALES BY PRODUCT LINE
Table RO-3: ROBERTET SALES BY GEOGRAPHIC REGION
Table SI-1: SENSIENT BUSINESS EVOLUTION MAJOR MILESTONES
Table SI-2: SENSIENT SALES AND OPERATING PROFIT GROWTH
Table SI-3: SENSIENT SALES BY GEOGRAPHIC REGION
Table SI-4: SENSIENT SALES GROWTH BY GEOGRAPHIC REGION
Table SI-5: SENSIENT SALES BY PRODUCT CATEGORY
Table SI-6: SENSIENT SALES GROWTH BY PRODUCT CATEGORY
Table SI-7: SENSIENT OPERATING PROFIT AND MARGINS BY PRODUCT CATEGORY
Table SI-8: SENSIENT SALES AND OPERATING PROFIT GROWTH
Table SY-1: SYMRISE BUSINESS EVOLUTION MAJORMILESTONES
Table SY-2: SYMRISE FLAGRANCE INTRODUCTIONS
Table SY-3: SYMRISE SALES BY GEOGRAPHIC REGION
Table SY-4: SYMRISE SALES BY PRODUCT CATEGORY
Table SY-5: SYMRISE SALES AND OPERATING PROFIT GROWTH
Table SY-6: SYMRISE SALES GROWTH BY GEOGRAPHIC REGION
Table SY-7: SYMRISE GROWTH BY PRODUCT CATEGORY
Table SY-8: SYMRISE SALES AND OPERATING PROFIT GROWTH
Table SY-9: SYMRISE SALES GROWTH BY GEOGRAPHIC REGION
Table SY-10: SYMRISE SALES GROWTH BY PRODUCT CATEGORY
Table TA-1: TAKASAGO BUSINESS EVOLUTION MAJOR MILESTONES
Table TA-2: TAKASAGO SALES AND OPERATING PROFIT GROWTH
Table TA-3: TAKASAGO SALES BY GEOGRAPHIC REGION
Table TA-4: TAKASAGO SALES BY PRODUCT CATEGORY
Table CA-1: TOP 10 WORLD’S LEADING FLAVOR AND FRAGRANCE COMPANIES SALES AND RANK
Table CA-2: TOP 10 WORLD’S LEADING FLAVOR AND FRAGRANCE COMPANIES SALES BY GEOGRAPHIC REGION
Table CA-3: TOP 10 WORLD’S LEADING FLAVOR AND FRAGRANCE COMPANIES SALES BY PRODUCT CATEGORY
Table CA-4: TOP 10 WORLD’S LEADING FLAVOR AND FRAGRANCE COMPANIES OPERATING PROFIT AND MARGINS
Table CA-5: TOP 10 WORLD’S LEADING FLAVOR AND FRAGRANCE COMPANIES SALES FORCE SIZE BY GEOGRAPHIC REGION"
"I. OUTLOOK

Introduction
Industry Consolidation and Diversification: A Biomodal Trend
Market Globalization
Pricing Pressures
Productivity

II. MAJOR GEOGRAPHIC REGIONS

North America
Europe
Japan
Latin America

III. MAJOR MODALITIES

Ray
Ultrasound
MRI
CT
Nuclear Medicine
PET
PACS

IV. MARKET SIZE AND GROWTH

V. LEADING DIAGNOSTIC IMAGING COMPANIES STRATEGIC DIRECTIONS

Business, new product development, and marketing strategies
Anticipated acquisitions, joint ventures, and divestitures

VI. LEADING DIAGNOSTIC IMAGING COMPANIES MARKETING TACTICS

The U.S. and international sales force size in major geographic regions
Selling options, including rental plans, leasing and others
Promotional tactics, e.g., pricing, discounts, advertising, trade shows, seminars, product literature, newsletters, etc
System service and support

VII. LEADING DIAGNOSTIC IMAGING COMPANIES TECHNOLOGICAL KNOW-HOW

Internally developed and acquired diagnostic imaging and related technologies, Including X  ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others.

LIST OF TABLES

Table 1: Worldwide Diagnostic Imaging Market Estimated Sales by Geographic Region and Country
Table 2: Worldwide Diagnostic Imaging Market Estimated Sales Growth by Geographic Region and Country
Table 3: Worldwide Diagnostic Imaging Market Estimated Sales by Modality and Business
Table 4: Worldwide Diagnostic Imaging Market Estimated Sales by Modality/Business And Geographic Region
Table 5: Worldwide Diagnostic Imaging Market Estimated Sales Growth by Modality/Business"
"Analogic
Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Tactics
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Esaote
Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction

GE

Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Hitachi
Executive Summary
Ownership
Business Evolution and Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Hologic
Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Philips
Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Shimadzu
Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Siemens
Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Toshiba
Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction

LIST OF TABLES

Worldwide Diagnostic Imaging Market Estimated Sales by Geographic Region and Country
Worldwide Diagnostic Imaging Market Estimated Sales Growth by Geographic Region and Country
Worldwide Diagnostic Imaging Market Estimated Sales by Modality and Business
Worldwide Diagnostic Imaging Market Estimated Sales by Modality/Business and Geographic Region
Worldwide Diagnostic Imaging Market Estimated Sales Growth by Modality/Business
Analogic Sales and Operating Profit Growth
Analogic Sales by Revenue Source
Analogic Sales Growth by Business Segment
Analogic Sales by Geographic Region
Analogic Sales Growth by Geographic Region
Esaote Sales and Operating Profit Growth
Esaote Sales by Business Segment
Esaote Sales Growth by Business Segment
Esaote Sales by Geographic Region/Country
GE Electric Diagnostic Imaging Worldwide Sales by Geographic Region
GE Electric Diagnostic Imaging Worldwide Sales by Modality/Business
GE Electric Diagnostic Imaging Worldwide Sales by Modality/Business and Geographic Region
GE Electric Diagnostic Imaging System Placements and Installed Base by Modality and Region
Hitachi Imaging Systems Sales by Geographic Region
Hitachi Imaging Systems Sales by Modality/Business
Hitachi Imaging Systems Sales by Modality/Business and Geographic Region
Hitachi Imaging Systems System Placements and Installed Base by Modality and Geographic Region
Hologic Sales and Operating Profit Growth
Hologic Sales by Product Line/Business
Hologic Sales Growth by Product Line/Business
Hologic Operating Profit by Product Line
Hologic Operating Profit Growth by Product Line
Hologic Sales by Geographic Region
Hologic Sales Product Growth by Geographic Region
Philips Healthcare Operating Profit Growth
Philips Healthcare Worldwide Sales by Geographic Region
Philips Healthcare Sales by Business
Philips Healthcare Imaging Systems Sales by Modality/Business
Philips Healthcare Diagnostic Imaging Profit and Margins by Modality
Phillips Medical Systems Sales by Modality/Business and Geographic Region
Phillips Medical Systems Placements and Installed Base by Modality and Geographic Region
Shimadzu Revenue by Product Category
Shimadzu Operating Profit by Product Category
Shimadzu Medical Systems Sales by Country
Shimadzu Medical Systems Worldwide Sales by Modality/Business
Shimadzu Imaging Systems Sales by Modality/Business and Geographic Region
Shimadzu Imaging Systems Placements and Installed Base by Modality and Geographic Region
Siemens Imaging System Sales by Geographic Region
Siemens Imaging System Worldwide Sales by Modality/Business
Siemens Imaging System Sales by Modality/Business and Geographic Region
Siemens Diagnostic Imaging Operating Profit and Margins by Modality/Business
Siemens Imaging System Placements and Installed Base by Modality and Geographic Region
Toshiba Medical Systems Sales by Modality/Business
Toshiba Medical Systems Operating Profit and Margins by Modality/Business
Toshiba Medical Systems Sales by Modality/Business and Geographic Region
Toshiba Medical System Placements and Installed Base By Modality/Business and Region"
"ANALOGIC

Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Tactics
Financial Analysis
Strengths and Weaknesses
Strategic Direction

ESAOTE

Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction

GE

Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction

HITACHI

Executive Summary
Ownership
Business Evolution and Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction

HOLOGIC

Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction

PHILIPS

Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction

SHIMADZU

Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Siemens
Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction

TOSHIBA

Executive Summary
Ownership
Business Evolution Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction

LIST OF TABLES

Worldwide Diagnostic Imaging Market Estimated Sales by Geographic Region and Country
Worldwide Diagnostic Imaging Market Estimated Sales Growth by Geographic Region and Country
Worldwide Diagnostic Imaging Market Estimated Sales by Modality and Business
Worldwide Diagnostic Imaging Market Estimated Sales by Modality/Business and Geographic Region
Worldwide Diagnostic Imaging Market Estimated Sales Growth by Modality/Business
Analogic Sales and Operating Profit Growth
Analogic Sales by Revenue Source
Analogic Sales Growth by Business Segment
Analogic Sales by Geographic Region
Analogic Sales Growth by Geographic Region
Esaote Sales and Operating Profit Growth
Esaote Sales by Business Segment
Esaote Sales Growth by Business Segment
Esaote Sales by Geographic Region/Country
GE Electric Diagnostic Imaging Worldwide Sales by Geographic Region
GE Electric Diagnostic Imaging Worldwide Sales by Modality/Business
GE Electric Diagnostic Imaging Worldwide Sales by Modality/Business and Geographic Region
GE Electric Diagnostic Imaging System Placements and Installed Base by Modality and Region
Hitachi Imaging Systems Sales by Geographic Region
Hitachi Imaging Systems Sales by Modality/Business
Hitachi Imaging Systems Sales by Modality/Business and Geographic Region
Hitachi Imaging Systems System Placements and Installed Base by Modality and Geographic Region
Hologic Sales and Operating Profit Growth
Hologic Sales by Product Line/Business
Hologic Sales Growth by Product Line/Business
Hologic Operating Profit by Product Line
Hologic Operating Profit Growth by Product Line
Hologic Sales by Geographic Region
Hologic Sales Product Growth by Geographic Region
Philips Healthcare Operating Profit Growth
Philips Healthcare Worldwide Sales by Geographic Region
Philips Healthcare Sales by Business
Philips Healthcare Imaging Systems Sales by Modality/Business
Philips Healthcare Diagnostic Imaging Profit and Margins by Modality
Phillips Medical Systems Sales by Modality/Business and Geographic Region
Phillips Medical Systems Placements and Installed Base by Modality and Geographic Region
Shimadzu Revenue by Product Category
Shimadzu Operating Profit by Product Category
Shimadzu Medical Systems Sales by Country
Shimadzu Medical Systems Worldwide Sales by Modality/Business
Shimadzu Imaging Systems Sales by Modality/Business and Geographic Region
Shimadzu Imaging Systems Placements and Installed Base by Modality and Geographic Region
Siemens Imaging System Sales by Geographic Region
Siemens Imaging System Worldwide Sales by Modality/Business
Siemens Imaging System Sales by Modality/Business and Geographic Region
Siemens Diagnostic Imaging Operating Profit and Margins by Modality/Business
Siemens Imaging System Placements and Installed Base by Modality and Geographic Region
Toshiba Medical Systems Sales by Modality/Business
Toshiba Medical Systems Operating Profit and Margins by Modality/Business
Toshiba Medical Systems Sales by Modality/Business and Geographic Region
Toshiba Medical System Placements and Installed Base By Modality/Business and Region"
"Global Paints and Coatings Market Dynamics and Trends
Worldwide strategic overview of the paints and coatings market
Sales forecasts for major market segments
Sales forecasts for key geographic regions: North America, Europe, Asia
Pacific, Latin America, Africa, Mideast
Major U.S. and international regulatory, technological, economic, demographic, and social trends with potentially significant impact on the paints and coatings industry during the next five years
Industry consolidation
Market globalization
Environmental regulations
Leading Paints and Coatings Companies Strategic Directions
Specific business, new product development and marketing strategies
Major strengths and weaknesses, e.g., managerial, organizational, marketing and product development
Anticipated acquisitions, joint ventures and divestitures
Leading Paints and Coatings Companies Marketing Tactics
Promotional tactics
Distribution approaches
Product service and support
Customer relations
Leading Paints and Coatings Companies Technological Know-How
Internally developed and acquired technologies, processes, and related capabilities
Proprietary technologies and patent litigations

LIST OF TABLES

Table MO-1 Worldwide Paints and Coatings Market by Geographic Region
Table MO-2 Worldwide Paints and Coatings Market Growth by Geographic Region
Table MO-3 Worldwide Paints and Coatings Sales by Market Segment